INSPIRIS RESILIA生物瓣行外科主动脉瓣置换的三年多中心结局
IMPACT注册研究为前瞻性多中心国际注册,5年随访,纳入556例严重主动脉狭窄行INSPIRIS RESILIA生物瓣外科置换患者,平均年龄63.4±8.5岁。3年总生存率91.0%,瓣膜相关死亡免除率97.5%,平均跨瓣压差11.9 mmHg,功能分级III/IV级从基线41.2%降至5.7%。
要点
- 3年总生存率91.0%,瓣膜相关死亡免除率97.5%,结构性瓣膜衰败2期免除率96.8%
- 3年平均跨瓣压差11.9 mmHg,指数化有效瓣口面积0.8 cm2/m2
- 功能分级III/IV级比例从基线41.2%改善至3年5.7%
核心结论
- INSPIRIS RESILIA生物瓣行外科主动脉瓣置换在真实世界严重主动脉狭窄人群中3年生存、血流动力学和功能状态结局良好。
研究设计与样本
- 患者平均年龄63.4±8.5岁,女性29.0%,EuroSCORE II 2.2±2.5%,STS评分1.7±2.2%。
主要发现
- 3年总生存率91.0%,瓣膜相关死亡免除率97.5%,人工瓣膜心内膜炎免除率96.0%,卒中免除率91.5%。
- 3年瓣膜相关功能障碍免除率98.0%,再干预免除率96.2%,结构性瓣膜衰败2期免除率96.8%,3期免除率99.4%。
- 3年平均跨瓣压差11.9 mmHg,指数化有效瓣口面积0.8 cm2/m2;功能分级III/IV级从基线41.2%降至3年5.7%。
临床怎么用
- 该3年数据可为严重主动脉狭窄患者选择INSPIRIS RESILIA生物瓣行外科主动脉瓣置换提供真实世界参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate 3-year outcomes of surgical aortic valve replacement using the INSPIRIS RESILIA aortic valve bioprosthesis in patients with severe aortic stenosis. METHODS: IMPACT registry is a prospective, multicentre, international registry with a 5-year follow-up. After 3 years, haemodynamic performance, all-cause mortality, and valve-related mortality were determined. RESULTS: A total of 556 patients who underwent surgical aortic valve replacement with the INSPIRIS RESILIA aortic valve were enrolled between December 2019 and June 2021. The mean age was 63.4 ± 8.5 years, 29.0% were female, with a EuroSCORE II of 2.2 ± 2.5% and an STS score of 1.7 ± 2.2%. Hypertension (66.2%), coronary artery disease (34.7%), and diabetes (18.4%) were the most common comorbidities. A total of 49.3% of patients underwent full sternotomy, 58.3% isolated aortic valve replacement. The most commonly implanted valve sizes were 23 mm (35.4%) and 25 mm (30.9%). At 3 years, overall survival was 91.0%, freedom from valve-related mortality was 97.5%, from prosthetic endocarditis 96.0%, from stroke 91.5%, from valve-related dysfunction 98.0%, from reintervention 96.2%, from structural valve deterioration stage 2 96.8%, and from stage 3 99.4%. The mean transvalvular gradient was 11.9 mmHg at 3 years, with an indexed effective orifice area of 0.8 cm2/m2. Functional class improved from 41.2% class III or IV at baseline to 5.7% at 3 years. CONCLUSIONS: Three-year outcomes, including survival and haemodynamic and functional status after surgical aortic valve replacement using the INSPIRIS RESILIA bioprosthetic aortic valve, were reported in a real-world patient population with severe aortic stenosis. CLINICALTRIALS.GOV: NCT04053088.
引用
- Bakhtiary F, Benedikt P, Bonaros N, et al. Three-Year Outcomes After Surgical Aortic Valve Replacement With a Bioprosthetic Valve from the Multi-Centre IMPACT Registry. Interdiscip Cardiovasc Thorac Surg. 2026. PMID: 41787958. doi:10.1093/icvts/ivag056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。